40.15

1.80% 0.71

Vericel Corp (VCEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$39.44

Offen:

$40.01

24-Stunden-Volumen:

481.43K

Relative Volume:

0.96

Marktkapitalisierung:

$2.06B

Einnahmen:

$292.09M

Nettoeinkommen (Verlust:

$21.46M

KGV:

98.14

EPS:

0.4091

Netto-Cashflow:

$47.49M

1W Leistung:

+1.11%

1M Leistung:

-1.81%

6M Leistung:

+17.60%

1J Leistung:

+27.38%

1-Tages-Spanne:

$39.37

$40.40

1-Wochen-Bereich:

$39.29

$41.08

52-Wochen-Spanne:

$28.95

$49.32

Vericel Corp Stock (VCEL) Company Profile

Firmenname

Vericel Corp

Sektor

Healthcare (1064)

Branche

Biotechnology (595)

Telefon

(734) 930-5555

Adresse

64 SIDNEY ST., CAMBRIDGE, MA

Mitarbeiter

398

Twitter

@VericelCorp

Nächster Verdiensttermin

2026-11-05

Neueste SEC-Einreichungen

VCEL's Discussions on Twitter

Compare VCEL vs VRTX, MRNA, REGN, ARGX, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VCEL Vericel Corp	40.15	2.03B	292.09M	21.46M	47.49M	0.4091
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Vericel Corp Stock (VCEL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-17	Herabstufung	BTIG Research	Buy → Neutral
2024-08-09	Eingeleitet	Canaccord Genuity	Buy
2024-06-20	Eingeleitet	TD Cowen	Buy
2024-01-25	Hochstufung	Truist	Hold → Buy
2023-08-08	Hochstufung	BTIG Research	Neutral → Buy
2022-11-10	Herabstufung	BTIG Research	Buy → Neutral
2022-11-09	Herabstufung	Truist	Buy → Hold
2022-10-14	Fortgesetzt	Stephens	Overweight
2021-01-11	Herabstufung	Oppenheimer	Outperform → Perform
2020-12-18	Eingeleitet	Stephens	Overweight
2020-09-17	Eingeleitet	Truist	Buy
2019-10-09	Eingeleitet	H.C. Wainwright	Buy
2019-02-28	Herabstufung	Needham	Buy → Hold
2018-08-08	Bestätigt	Needham	Buy
2018-07-16	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2018-04-04	Eingeleitet	Leerink Partners	Outperform
2018-03-06	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2018-03-06	Bestätigt	Needham	Buy
2018-03-05	Bestätigt	BTIG Research	Buy
2017-06-21	Eingeleitet	BTIG Research	Buy
2017-03-13	Bestätigt	Needham	Buy
2016-12-22	Eingeleitet	Piper Jaffray	Overweight
2016-11-09	Bestätigt	Needham	Buy
2016-04-05	Herabstufung	BofA/Merrill	Buy → Neutral
2016-03-11	Hochstufung	Needham	Hold → Buy

Alle ansehen

Vericel Corp Aktie (VCEL) Neueste Nachrichten

Sep 26, 2026

Vericel Corporation at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus

Sep 16, 2026

Sep 14, 2026

Vericel's MACI growth and new contracts boost i... - Pluang

Sep 14, 2026

Sep 09, 2026

ETFs Investing in Vericel Corporation Stocks - TradingView

Sep 09, 2026

Sep 08, 2026

Morgan Stanley will host Vericel at a healthcare conference Sept. 15 - Stock Titan

Sep 08, 2026

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026 - marketscreener.com

Sep 08, 2026

Sep 05, 2026

Vericel (NASDAQ:VCEL) Stands Out on the Affordable Growth Screen - ChartMill

Sep 05, 2026

Aug 21, 2026

Madison Asset Management LLC Acquires Shares of 50,116 Vericel Corporation $VCEL - MarketBeat

Aug 21, 2026

Aug 20, 2026

M3Sixty Small Cap Growth Fund's Vericel Corp(VCEL) Holding History - GuruFocus

Aug 20, 2026

Aug 19, 2026

Summit Creek Advisors LLC Purchases Shares of 219,312 Vericel Corporation $VCEL - MarketBeat

Aug 19, 2026

Aug 18, 2026

TimesSquare Capital Management LLC Invests $24.46 Million in Vericel Corporation $VCEL - MarketBeat

Aug 18, 2026

Aug 17, 2026

Oppenheimer Asset Management Inc. Invests $1.03 Million in Vericel Corporation $VCEL - MarketBeat

Aug 17, 2026

VCEL|Vericel Corp|Price:43.560|Chg%:-0.640 - TradingKey

Aug 17, 2026

Aug 15, 2026

Vericel Corporation $VCEL Shares Purchased by Bank of America Corp DE - MarketBeat

Aug 15, 2026

Aug 14, 2026

Vericel Corp Director Kevin McLaughlin Executes Stock Options and Sells Shares Under 10b5-1 Plan - Kalkine Media

Aug 14, 2026

Vericel (VCEL) director exercises 7,000 options and sells 7,000 shares - Stock Titan

Aug 14, 2026

Vericel (NASDAQ:VCEL): A Strong Growth Play With an Improving Technical Setup - ChartMill

Aug 14, 2026

Aug 13, 2026

Soleus Capital group (VCEL) discloses 2.8% Vericel ownership under 5% level - Stock Titan

Aug 13, 2026

Aug 12, 2026

Kevin McLaughlin (VCEL) to sell 7,000 shares after stock option exercise - Stock Titan

Aug 12, 2026

Aug 11, 2026

Vericel Corp (NASDAQ:VCEL): Growth at a Reasonable Price - ChartMill

Aug 11, 2026

Vericel Corporation $VCEL Shares Sold by Kopp Family Office LLC - MarketBeat

Aug 11, 2026

Aug 10, 2026

3 Major Earnings Winners You May Have Missed - MarketBeat

Aug 10, 2026

Aug 09, 2026

Vericel Corporation $VCEL Shares Bought by First Trust Advisors LP - MarketBeat

Aug 09, 2026

Aug 07, 2026